Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
UnitedHealth Group Analyst Ratings
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating
UnitedHealth (UNH) Gets a Buy From Cantor Fitzgerald
Jefferies Upgrades UnitedHealth to Buy, Cites Growth Outlook
Barclays Keeps Their Buy Rating on UnitedHealth (UNH)
Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH) and Biogen (BIIB)
UnitedHealth Group Maintains Buy Rating: Sustainable Growth and Strategic Positioning Fuel Long-Term Trajectory
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)
UnitedHealth Group Analyst Ratings
RBC Raises Price Target on UnitedHealth Group to $615 From $555, Keeps Outperform Rating
Jefferies Upgrades UnitedHealth to Buy From Hold, Adjusts Price Target to $647 From $481
Analysts' Top Healthcare Picks: UnitedHealth (UNH), Immutep (IMMP)
UNH Earnings: UnitedHealth Posts Q2 Beat but Cyberattack Overhang Remains
TD Cowen Remains a Buy on UnitedHealth (UNH)
UnitedHealth Buy Rating Affirmed Amidst Medicare Advantage Growth and Positive Sector Outlook
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Roche Holding AG (OtherRHHVF) and UnitedHealth (UNH)
Cantor Fitzgerald Keeps Their Buy Rating on UnitedHealth (UNH)